These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21771730)

  • 21. Enhancing metabolic monitoring for children and adolescents using second-generation antipsychotics.
    Coughlin M; Goldie CL; Tregunno D; Tranmer J; Kanellos-Sutton M; Khalid-Khan S
    Int J Ment Health Nurs; 2018 Jun; 27(3):1188-1198. PubMed ID: 29205757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bridging the gap from evidence to policy and practice: reducing the progression to metabolic syndrome for children and adolescents on antipsychotic medication.
    Eapen V; Shiers D; Curtis J
    Aust N Z J Psychiatry; 2013 May; 47(5):435-42. PubMed ID: 23047958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antipsychotics use in children and adolescents: An on-going challenge in clinical practice.
    Schneider C; Taylor D; Zalsman G; Frangou S; Kyriakopoulos M
    J Psychopharmacol; 2014 Jul; 28(7):615-23. PubMed ID: 24902872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atypical antipsychotics in the treatment of children and adolescents.
    Findling RL
    J Clin Psychiatry; 2004; 65 Suppl 6():3-4. PubMed ID: 15104520
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of antipsychotic medication on psychiatric service utilization and cost.
    Rothbard A; Murrin MR; Jordan N; Kuno E; McFarland BH; Stroup TS; Morrissey JP; Stiles PG; Boothroyd RA; Merwin E; Shern DL
    J Ment Health Policy Econ; 2005 Jun; 8(2):83-93. PubMed ID: 15998980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antipsychotic use at adult ambulatory care visits by patients with mental health disorders in the United States, 1996-2003: national estimates and associated factors.
    Sankaranarayanan J; Puumala SE
    Clin Ther; 2007 Apr; 29(4):723-41. PubMed ID: 17617297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of patients' preexisting metabolic risk factors on the choice of antipsychotics by office-based physicians.
    Li C; Mittal D; Owen RR
    Psychiatr Serv; 2011 Dec; 62(12):1477-84. PubMed ID: 22193796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antipsychotic safety and efficacy concerns.
    Meyer JM
    J Clin Psychiatry; 2007; 68 Suppl 14():20-6. PubMed ID: 18284274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Off-label second generation antipsychotics for impulse regulation disorders: a review.
    Scheltema Beduin A; de Haan L
    Psychopharmacol Bull; 2010; 43(3):45-81. PubMed ID: 21150846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hepatic tolerance of atypical antipsychotic drugs].
    Dumortier G; Cabaret W; Stamatiadis L; Saba G; Benadhira R; Rocamora JF; Aubriot-Delmas B; Glikman J; Januel D
    Encephale; 2002; 28(6 Pt 1):542-51. PubMed ID: 12506267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychotropic medication use in children and adolescents in an inpatient setting.
    Pejovic-Milovancevic M; Miletic V; Popovic-Deusic S; Draganic-Gajic S; Lecic-Tosevski D; Marotic V
    Psychiatriki; 2011; 22(4):314-9. PubMed ID: 22271844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Reaction on 'Antipsychotics and metabolic abnormalities in children and adolescents a review of the literature and some recommendations'].
    Roke Y
    Tijdschr Psychiatr; 2010; 52(7):535-6; discussion 536. PubMed ID: 20623452
    [No Abstract]   [Full Text] [Related]  

  • 33. Molecular study of weight gain related to atypical antipsychotics: clinical implications of the CYP2D6 genotype.
    Nussbaum LA; Dumitraşcu V; Tudor A; Grădinaru R; Andreescu N; Puiu M
    Rom J Morphol Embryol; 2014; 55(3):877-84. PubMed ID: 25329115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New users of antipsychotic medications among children enrolled in TennCare.
    Cooper WO; Hickson GB; Fuchs C; Arbogast PG; Ray WA
    Arch Pediatr Adolesc Med; 2004 Aug; 158(8):753-9. PubMed ID: 15289247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of antidepressants and antipsychotics on weight gain in children and adolescents.
    Reekie J; Hosking SP; Prakash C; Kao KT; Juonala M; Sabin MA
    Obes Rev; 2015 Jul; 16(7):566-80. PubMed ID: 26016407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of behavior disorders in mental retardation: report on transitioning to atypical antipsychotics, with an emphasis on risperidone.
    Aman MG; Gharabawi GM;
    J Clin Psychiatry; 2004 Sep; 65(9):1197-210. PubMed ID: 15367046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adverse events in children and adolescents treated with antipsychotic medications.
    Jerrell JM; McIntyre RS
    Hum Psychopharmacol; 2008 Jun; 23(4):283-90. PubMed ID: 18302312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology and characteristics of emergency departments visits by US adults with psychiatric disorder and antipsychotic mention from 2000 to 2004.
    Sankaranarayanan J; Puumala SE
    Curr Med Res Opin; 2007 Jun; 23(6):1375-85. PubMed ID: 17594776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiologic features of antipsychotic prescribing to children and adolescents in primary care in the United Kingdom.
    Rani F; Murray ML; Byrne PJ; Wong IC
    Pediatrics; 2008 May; 121(5):1002-9. PubMed ID: 18450906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Challenges of the use of antipsychotics in children and adolescents].
    Portnova AA; Sivolap YP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(11):123-127. PubMed ID: 31851183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.